Reshma Singh, Ph.D.

2006 University of Pennsylvania, Philadelphia, PA, United States 
Immunology, Microbiology Biology, Oncology
"Reshma Singh"


Sign in to add mentor
Yvonne Paterson grad student 2006 Penn
 (Listeria monocytogenes-based vaccines for HER-2/neu overexpressing breast cancers.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hannan R, Zhang H, Wallecha A, et al. (2012) Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer. Cancer Immunology, Immunotherapy : Cii. 61: 2227-38
Singh R, Cresswell P. (2010) Defective cross-presentation of viral antigens in GILT-free mice Science. 328: 1394-1398
Singh R, Jamieson A, Cresswell P. (2008) GILT is a critical host factor for Listeria monocytogenes infection Nature. 455: 1244-1247
Singh R, Paterson Y. (2007) Immunoediting sculpts tumor epitopes during immunotherapy. Cancer Research. 67: 1887-92
Singh R, Paterson Y. (2007) In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccines. Cancer Immunology, Immunotherapy : Cii. 56: 927-38
Singh R, Paterson Y. (2006) Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy. Expert Review of Vaccines. 5: 541-52
Singh R, Paterson Y. (2006) Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer. Cancer Research. 66: 7748-57
Singh R, Dominiecki ME, Jaffee EM, et al. (2005) Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse. Journal of Immunology (Baltimore, Md. : 1950). 175: 3663-73
See more...